Purchase Order SPE2DP25P0179
Award Date 1/15/25
Potential Completion Date 1/30/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lake Zurich, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price purchase order contract awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical supplies, for the delivery of blood packs with anticoagulant. The contract has a ceiling value of $3,303.84 and an ultimate completion date of August 18, 2025. Fenwal, Inc. is a global blood technology company and subsidiary of Fresenius Kabi, located in Lake Zurich, Illinois. The company is a registered vendor with the U.S. federal...
- This federal contract award from the Defense Logistics Agency (DLA) is for the provision of blood collection supplies to support medical and healthcare initiatives. The $5,743.25 firm-fixed-price purchase order was awarded to Fenwal, Inc., a foreign-owned, for-profit manufacturer of blood collection, separation, storage, and transfusion products and services. The contract has a performance period ending on March 26, 2025 and does not include a set-aside designation. Fenwal, Inc. is a key...
- Fenwal, Inc., a Lake Zurich, Illinois-based blood technology company and subsidiary of Fresenius Kabi, was awarded a $1,101.28 firm fixed-price purchase order by the Defense Logistics Agency (DLA) on June 18, 2025, for a blood pack with anticoagulant. The contract, which carries an ultimate completion date of August 18, 2025, represents a continuation of Fenwal's established role as a critical supplier of specialized blood collection and transfusion products to the federal government. This award...
- This $1,839.04 firm-fixed-price purchase order was awarded by the Defense Logistics Agency Troop Support Medical, a component of the U.S. Department of Defense, to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The contract is for the delivery of 8510030904 - BLOOD PACK WITH ANT, a medical supply item used in transfusion medicine and cell therapy applications. Fenwal, a registered government vendor since 2007, has a history of providing a diverse array of...
- The U.S. government awarded a firm-fixed-price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi located in Lake Zurich, Illinois. The $85,899.84 contract is to provide blood packs with anticoagulant to the Defense Logistics Agency (DLA), which serves as the medical supply chain for the U.S. Department of Defense. The contract has an ultimate completion date of July 21, 2025 and was awarded on May 22, 2025. Fenwal, Inc. is a registered...
- This firm fixed-price purchase order was awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a global medical technology company based in Lake Zurich, Illinois. The $1,486.54 contract is for the supply of a washing solution, a specialized medical product that supports healthcare and biomedical research initiatives. Fenwal, Inc. is a foreign-owned, for-profit manufacturer registered as a vendor with the U.S. federal government since 2007 and has a history of securing contracts from...
- This firm fixed-price purchase order (SPE2DP20V0090) was awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of specialized medical equipment and consumables. The $1,081.44 contract is for the supply of a diluting solution (8506977469) and does not have a set-aside designation. Fenwal, Inc. is a critical supplier to various federal agencies, providing products that support healthcare and biomedical research initiatives, including military...
- The Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price purchase order to Fenwal, Inc. for blood packs with anticoagulant, with a ceiling value of $3,462. The award, issued on July 31, 2018, with an ultimate completion date of August 6, 2018, represents a routine consumable procurement for military medical supply operations. No set-aside designation was used for this acquisition, reflecting Fenwal's established position as a qualified supplier of specialized blood products...
- This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Fenwal, Inc., a Fresenius Kabi company, for the supply of specialized blood collection, separation, storage, and transfusion products and services. The $1,176.75 contract will support the U.S. military's frozen blood program and provide consumables, cell processing kits, separators, and service agreements to facilitate biomedical research and blood banking operations for the federal government. Fenwal, a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price purchase order contract to Fenwal, Inc., a global blood technology company and subsidiary of Fresenius Kabi. The $2,353.50 contract, awarded on May 30, 2024, is for the delivery of medical supplies and equipment such as washing solutions, diluting solutions, anticoagulants, blood collection assemblies, donor tubing strippers, and other products supporting transfusion medicine and cell therapy applications....
This is a $1,101.28 firm fixed-price purchase order awarded by the Defense Logistics Agency (DLA) to Fenwal, Inc., a foreign-owned, for-profit manufacturer of medical products based in Lake Zurich, Illinois. The contract is for the delivery of "BLOOD PACK WITH ANT" and has an ultimate completion date of January 30, 2025. Fenwal, Inc. is a global blood technology company and a key supplier to various federal agencies, providing critical medical supplies and equipment that support healthcare and biomedical research initiatives. The contract does not have a set-aside designation, reflecting Fenwal's specialized expertise in transfusion medicine and cell therapy technologies. This award is not associated with a larger contract vehicle.
Generated 5/30/25, 9:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 1/15/25 |